Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-13-107746
Filing Date
2013-03-14
Accepted
2013-03-14 17:20:46
Documents
13
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d443981d10k.htm 10-K 1249707
2 EX-10.31 d443981dex1031.htm EX-10.31 12000
3 EX-23.1 d443981dex231.htm EX-23.1 2272
4 EX-31.1 d443981dex311.htm EX-31.1 8461
5 EX-31.2 d443981dex312.htm EX-31.2 8436
6 EX-32.1 d443981dex321.htm EX-32.1 8040
13 GRAPHIC g443981g48y81.jpg GRAPHIC 49561
  Complete submission text file 0001193125-13-107746.txt   6842566

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT orex-20121231.xml EX-101.INS 926497
8 XBRL TAXONOMY EXTENSION SCHEMA orex-20121231.xsd EX-101.SCH 66787
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE orex-20121231_cal.xml EX-101.CAL 61460
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE orex-20121231_def.xml EX-101.DEF 333995
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE orex-20121231_lab.xml EX-101.LAB 509451
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orex-20121231_pre.xml EX-101.PRE 383902
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

EIN.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33415 | Film No.: 13691336
SIC: 2834 Pharmaceutical Preparations